QR Code

Prospective Biomarkers of SARS-CoV-2 Vaccine Seroconversion in Patients with Haematological Malignancies

Background: SARS-CoV-2 vaccination is crucial for protecting against severe COVID-19 disease; however, patients with haematological malignancies (HM) respond poorly to vaccination due to immunosuppression driven by chemotherapy, targeted cell depletion, and immune dysregulation. We sought to define...

Full description

Saved in:
Main Authors: Sophie C. Hamann, Katie E. Lineburg, Louise Ng, Annabel Waugh, Stuart Olver, Justine Leach, Christine Bristow, Jyothy Raju, Laetitia Le Texier, Pauline Crooks, Corey Smith, Kristyan Guppy-Coles, Kirk Morris, Michelle Spanevello, Siok-Keen Tey, Andrea S. Henden
Format: Artigo
Language:Inglês
Published: MDPI AG 2026-02-01
Series:Vaccines
Subjects:
SARS-CoV-2
vaccination
haematological malignancy
immune responses
Online Access:https://www.mdpi.com/2076-393X/14/3/201
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items